Physician

Meera Sivalingam, MD

According to 2025 Medicare claims, Meera Sivalingam, MD (NPI: 1700318193) practices ophthalmology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 19006-6311.

Sivalingam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,429 traditional Medicare patients, billed 29,721 HCPCS/CPT codes, and received $3,553,644 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 733 prescription claims across 240 beneficiaries totaling $28,398 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 9 records totaling $2,166. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,167 and ending at $28,398. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2021 Medicare payment: $126,818 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $183,959 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $689,832 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,553,644 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021343942$126,818
20225311,252$183,959
20236744,379$689,832
20241,42929,721$3,553,644

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$34K2017 Drug cost: $1,167 (USD; Tot_Drug_Cst)2018 Drug cost: $6,146 (USD; Tot_Drug_Cst)2019 Drug cost: $18,158 (USD; Tot_Drug_Cst)2020 Drug cost: $25,228 (USD; Tot_Drug_Cst)2021 Drug cost: $33,941 (USD; Tot_Drug_Cst)2022 Drug cost: $21,857 (USD; Tot_Drug_Cst)2023 Drug cost: $10,869 (USD; Tot_Drug_Cst)2024 Drug cost: $28,398 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171634$1,167
201876172$6,146
2019173411$18,158
2020168412$25,228
2021168502$33,941
2022153375$21,857
2023127258$10,869
2024240733$28,398

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more429429$130
67028Injection of drug into eye4912,167$106
92014Established patient complete exam of visual system360414$96
92012Established patient problem focused exam of visual system7301,825$72
92134Imaging of retina1,3433,696$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate32312,045$17,261
Ketorolac TromethamineKetorolac Tromethamine1463,880$4,021
Atropine SulfateAtropine Sulfate25920$926
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat504,076$830
OfloxacinOfloxacin381,104$627

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$2,166Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Meera Sivalingam, MD?

Tedicare shows public-source Medicare data for Meera Sivalingam, MD (NPI 1700318193), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Meera Sivalingam, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Meera Sivalingam, MD?

Meera Sivalingam, MD is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Meera Sivalingam, MD have Open Payments data?

Meera Sivalingam, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.